LAURA NICHOLSON: Open Payments
NPI 1770848558 · NEWBURGH, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,393 in 13 payments from 11 companies in 2025. Trend: 2023 $1,153 · 2024 $1,103 · 2025 $1,393
Food & beverage: $1,393
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 3 | $283 |
| Abbott Laboratories | 1 | $134 |
| Teva Pharmaceuticals USA, Inc. | 1 | $128 |
| Agios Pharmaceuticals, Inc. | 1 | $128 |
| GENZYME CORPORATION | 1 | $125 |
| Lilly USA, LLC | 1 | $125 |
| Neurelis, Inc. | 1 | $120 |
| ARGENX US, INC. | 1 | $103 |
| Neurocrine BioSciences, Inc. | 1 | $101 |
| Novartis Pharmaceuticals Corporation | 1 | $82 |
Products named: Auvelity, PROCLAIM, PYRUKYND, DUPIXENT, ZEPBOUND, VALTOCO, VYVGART, INGREZZA.
Industry payments across NY — which companies pay providers there.
